Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $3.37M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| FBLG | FIBROBIOLOGICS INC | $13.79M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PSTV | PLUS THERAPEUTICS INC | $38.48M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NRXP | NRX PHARMACEUTICALS INC | $52.96M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NAKA | NAKAMOTO INC | $100.73M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SLE | SUPER LEAGUE ENTERPRISE INC | $2.82M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RCKT | ROCKET PHARMACEUTICALS INC | $459.94M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $26.46M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| OSTX | OS THERAPIES INC | $45.78M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PDSB | PDS BIOTECHNOLOGY CORP | $32.28M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TLRY | TILRAY BRANDS INC | $922.73M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ACET | ADICET BIO INC | $70.50M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SGMO | SANGAMO THERAPEUTICS INC | $158.83M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VNRX | VOLITIONRX LTD | $23.82M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| IFRX | INFLARX NV | $59.75M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ENLV | ENLIVEX LTD | $27.94M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GUTS | FRACTYL HEALTH INC | $66.33M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SNTI | SENTI BIOSCIENCES INC | $24.45M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TVRD | TVARDI THERAPEUTICS INC | $35.09M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HUMA | HUMACYTE INC | $209.74M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ACRV | ACRIVON THERAPEUTICS INC | $47.33M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TNYA | TENAYA THERAPEUTICS INC | $101.90M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $32.13M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PALI | PALISADE BIO INC | $266.72M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INTZ | INTRUSION INC | $18.07M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $159.18M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MREO | MEREO BIOPHARMA GROUP PLC | $63.33M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CTSO | CYTOSORBENTS CORP | $43.33M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HOVR | NEW HORIZON AIRCRAFT LTD | $84.08M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CAN | CANAAN INC | $331.63M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CABA | CABALETTA BIO INC | $316.71M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| APRE | APREA THERAPEUTICS INC | $5.05M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HELP | CYBIN INC | $367.72M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DEFT | DEFI TECHNOLOGIES INC | $246.00M | N/A | N/A | N/A | N/A | N/A | N/A | ||
| TCRX | TSCAN THERAPEUTICS INC | $59.59M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BIOX | BIOCERES CROP SOLUTIONS CORP | $36.04M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| DARE | DARE BIOSCIENCE INC | $23.72M | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.